Annual EBITDA
$2.20B$159.40M+7.82%
Summary
- Current Value
- As of today, LH annual EBITDA is $2.20B, up +7.82% on
- Historical Performance
- LH annual EBITDA is down -4.02% over the past 3 years, down -42.09% over the past 5 years
- All-Time High Comparison
- LH annual EBITDA is currently -48.91% below its historical high of $4.30B set on
- 3-Year Low Comparison
- LH annual EBITDA is +28.90% above its 3-year low of $1.70B reached on
- Sector Comparison
- LH annual EBITDA is higher than 95.72% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.20B | +7.8% | -4.0% | -42.1% | +80.4% | |
| Quarterly EBITDA | $560.50M | +12.3% | +16.4% | -57.2% | +74.2% | |
| TTM EBITDA | $2.26B | +25.7% | +4.1% | -50.6% | +80.9% | |
| Price | $253.01 | +2.2% | +32.8% | +7.7% | +207.2% | |
| PE Ratio | 22.42 | -21.5% | +29.5% | +156.5% | +44.0% | |
| Annual Revenue | $13.95B | +7.3% | +17.6% | -0.2% | +178.8% | |
| Annual EPS | $10.46 | +18.3% | -25.1% | -34.1% | +97.5% | |
| $1.52B | +33.2% | -13.5% | -48.9% | +49.2% | ||
| Annual Net Income | $877.70M | +17.5% | -12.5% | -43.6% | +53.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.29B | N/A | -4.0% |
| 5Y | $4.30B | -48.9% | |
| All | $4.30B | -48.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.70B | +28.9% | |
| 5Y | $1.70B | +28.9% | |
| All | $17.50M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of LH?
As of today, LH annual EBITDA is $2.20B
What is 1-year change in LH annual EBITDA?
LH annual EBITDA is up +7.82% year-over-year
What is 3-year change in LH annual EBITDA?
LH annual EBITDA is down -4.02% over the past 3 years
How far is LH annual EBITDA from its all-time high?
LH annual EBITDA is currently -48.91% below its historical high of $4.30B set on December 31, 2021
How does LH annual EBITDA rank versus sector peers?
LH annual EBITDA is higher than 95.72% of companies in Healthcare sector
When is LH next annual earnings release?
As of today, the next annual earnings release for LH has not been scheduled
Quarterly EBITDA
$560.50M$5.50M+0.99%
Summary
- Current Value
- As of today, LH quarterly EBITDA is $560.50M, up +0.99% on
- Historical Performance
- LH quarterly EBITDA is up +12.28% year-over-year, up +16.38% over the past 3 years
- All-Time High Comparison
- LH quarterly EBITDA is currently -63.55% below its historical high of $1.54B set on
- 3-Year Low Comparison
- LH quarterly EBITDA is +47.77% above its 3-year low of $379.30M reached on
- Sector Comparison
- LH quarterly EBITDA is higher than 95.49% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $560.50M | +1.0% | +12.3% | +16.4% | -57.2% | |
| Annual EBITDA | $2.20B | – | +7.8% | -4.0% | -42.1% | |
| TTM EBITDA | $2.26B | +2.8% | +25.7% | +4.1% | -50.6% | |
| Price | $253.01 | -8.4% | +2.2% | +32.8% | +7.7% | |
| PE Ratio | 22.42 | -15.1% | -21.5% | +29.5% | +156.5% | |
| Quarterly Revenue | $3.54B | +0.6% | +5.8% | +16.4% | -15.0% | |
| Quarterly EPS | $3.35 | +69.2% | +32.7% | +40.0% | -57.1% | |
| $387.20M | +1.4% | +16.5% | +14.1% | -64.0% | ||
| Quarterly Net Income | $278.00M | +68.6% | +30.5% | +33.4% | -63.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $574.20M | -2.4% | |
| 3Y | $574.20M | -2.4% | |
| 5Y | $1.31B | N/A | -57.2% |
| All | $1.54B | -63.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $499.20M | N/A | +12.3% |
| 3Y | $379.30M | +47.8% | |
| 5Y | $379.30M | +47.8% | |
| All | -$132.70M | +522.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of LH?
As of today, LH quarterly EBITDA is $560.50M
What is LH quarterly EBITDA most recent change?
LH quarterly EBITDA was up +0.99% on March 31, 2026
What is 1-year change in LH quarterly EBITDA?
LH quarterly EBITDA is up +12.28% year-over-year
How far is LH quarterly EBITDA from its all-time high?
LH quarterly EBITDA is currently -63.55% below its historical high of $1.54B set on December 31, 2020
How does LH quarterly EBITDA rank versus sector peers?
LH quarterly EBITDA is higher than 95.49% of companies in Healthcare sector
When is LH next earnings release?
The next earnings release for LH is on
TTM EBITDA
$2.26B$61.30M+2.79%
Summary
- Current Value
- As of today, LH TTM EBITDA is $2.26B, up +2.79% on
- Historical Performance
- LH TTM EBITDA is up +25.66% year-over-year, up +4.06% over the past 3 years
- All-Time High Comparison
- LH TTM EBITDA is currently -55.48% below its historical high of $5.07B set on
- 3-Year Low Comparison
- LH TTM EBITDA is +28.37% above its 3-year low of $1.76B reached on
- Sector Comparison
- LH TTM EBITDA is higher than 95.76% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.26B | +2.8% | +25.7% | +4.1% | -50.6% | |
| Annual EBITDA | $2.20B | – | +7.8% | -4.0% | -42.1% | |
| Quarterly EBITDA | $560.50M | +1.0% | +12.3% | +16.4% | -57.2% | |
| Price | $253.01 | -8.4% | +2.2% | +32.8% | +7.7% | |
| PE Ratio | 22.42 | -15.1% | -21.5% | +29.5% | +156.5% | |
| TTM Revenue | $14.14B | +1.4% | +7.3% | +13.1% | -7.7% | |
| TTM EPS | $11.28 | +7.9% | +30.2% | +2.5% | -58.0% | |
| $1.57B | +3.6% | +37.6% | +0.9% | -58.3% | ||
| TTM Net Income | $942.70M | +7.4% | +28.8% | +13.6% | -64.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.26B | at high | |
| 3Y | $2.26B | at high | |
| 5Y | $5.07B | -55.5% | |
| All | $5.07B | -55.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.80B | N/A | +25.7% |
| 3Y | $1.76B | +28.4% | |
| 5Y | $1.76B | +28.4% | |
| All | $17.60M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of LH?
As of today, LH TTM EBITDA is $2.26B
What is LH TTM EBITDA most recent change?
LH TTM EBITDA was up +2.79% on March 31, 2026
What is 1-year change in LH TTM EBITDA?
LH TTM EBITDA is up +25.66% year-over-year
How far is LH TTM EBITDA from its all-time high?
LH TTM EBITDA is currently -55.48% below its historical high of $5.07B set on June 30, 2021
How does LH TTM EBITDA rank versus sector peers?
LH TTM EBITDA is higher than 95.76% of companies in Healthcare sector
When is LH next earnings release?
The next earnings release for LH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- LH Official Website www.labcorp.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/920148/000092014826000111/0000920148-26-000111-index.htm
- LH Profile on Yahoo Finance finance.yahoo.com/quote/LH
- LH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lh